AOSLO-Based Precise Measurement of Retinal Hemodynamics: Development and Application Assessment
Establishment and Application Evaluation of a Precise and Accurate Measurement Method for Retinal Hemodynamics Based on Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO)
1 other identifier
observational
120
0 countries
N/A
Brief Summary
Changes in retinal hemodynamics play a key role in the development of various eye diseases. Currently, mainstream hemodynamic evaluation techniques have low resolution and poor measurement accuracy, limiting their widespread application. Adaptive optical laser scanning ophthalmoscopy (AO-SLO) can capture retinal vascular images at the cellular level, offering the potential for high-precision retinal hemodynamic evaluation. This project will: ① innovate the AO-SLO blood flow imaging scanning module and acquisition mode, develop algorithms for extracting spatiotemporal signal features from blood flow images, and achieve quantitative analysis of retinal hemodynamics based on AO-SLO; ② construct an in vitro retinal hemodynamic measurement simulation eye, conduct multidimensional AO-SLO hemodynamic measurements, and establish an intelligent model for precise calibration of retinal hemodynamic parameters; ③ conduct AO-SLO-based retinal hemodynamic studies in high myopia, integrating multi-modal ophthalmic imaging to investigate the patterns of changes in retinal vascular structure and blood flow function in high myopia. Ultimately, a new precision measurement imaging technology platform for retinal hemodynamics will be established.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2025
CompletedStudy Start
First participant enrolled
June 25, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedJuly 4, 2025
February 1, 2025
1 month
June 18, 2025
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Blood flow velocity in the central arteries and veins of the retina
Measure the blood flow velocity and flow velocity standard deviation of the central arteries and veins of the retina of the subject using an adaptive optical laser scanning ophthalmoscope.
7 days after the enrollment
The structure of central retinal arteries and veins
Measure the diameter of the central arteries and veins of the retina, the thickness of the vessel walls, and the wall-to-lumen ratio of the subjects using an adaptive optics laser scanning ophthalmoscope.
7 days after the enrollment
Retinal and choroidal capillary morphological parameters
Use OCTA to obtain images of superficial and deep capillaries and choroidal capillaries within a 3×3 mm area of the posterior pole of the retina, and use a proprietary algorithm to extract morphological parameters.
7 days after the enrollment
Secondary Outcomes (5)
The examination for anterior segment of eyes
Baseline
Axis of the eye
Baseline
Best corrected vision cutiy
Baseline
Intraocular pressure
Baseline
Fundus color photography
Baseline
Study Arms (2)
myopia, low and middle grade
myopia, high grade
Eligibility Criteria
The people From Guangzhou, Guangdong Province, China
You may qualify if:
- Participants must understand the clinical study and voluntarily participate, and sign an informed consent form;
- Age 18-30 years old, no gender restrictions;
- Equivalent spherical power≤0D cylindrical power -2.0D to +2.0D, best-corrected visual acuity ≥ 1.0
You may not qualify if:
- Participants with significant refractive media opacity-related conditions (severe cataracts, vitreous diseases, corneal diseases, etc.) at screening, or unable to complete or cooperate with routine ophthalmic examinations;
- History of or concurrent conditions such as ptosis, nystagmus, diabetic retinopathy, various macular degeneration, retinal vascular diseases, optic nerve inflammatory diseases, primary angle-closure glaucoma, various secondary glaucoma, amblyopia, or severe strabismus
- History of previous eye surgery
- Patients with severe hypertension, diabetes, or other systemic diseases that cause secondary changes in the retina
- Patients with posterior scleral staphyloma, lacquer cracks, choroidal neovascularization, or Fuchs' spots
- Pregnant women, breastfeeding women, monocular individuals, and individuals with disabilities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2025
First Posted
July 4, 2025
Study Start
June 25, 2025
Primary Completion
July 31, 2025
Study Completion
August 31, 2025
Last Updated
July 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR